Related Experiment Video
Updated: Aug 30, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Novel HIV-1 protease inhibitors active against multiple PI-resistant viral strains: coadministration with indinavir
Nancy J Kevin1, Joseph L Duffy, Brian A Kirk
1Department of Basic Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA.
Abstract:
HIV-1 protease inhibitors (PI) with an N-arylpyrrole moiety in the P(3) position afforded excellent antiviral potency and substantially improved aqueous solubility over previously reported variants. The rapid in vitro clearance of these compounds in human liver microsomes prompted oral coadministration with indinavir to hinder their metabolism by the cyctochrome P450 3A4 isozyme and allow for in vivo PK assessment.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Inhibitors Of Virion Release
Retrovirus Life Cycles
Subviral Agents

